Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2514 participants.

Also called NCT07052799

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 2,514 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07052799
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hong Kong SAR China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07052799. Randomized; quadruple masking; primary purpose prevention. Start 2026-02-10 (actual); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Condition
Myocardial Infarction (MI)
Condition
Cardiovascular Events
Condition
Post Polypectomy Bleeding in Antiplatelet Patients
Intervention (Drug)
Aspirin 80mg
Intervention (Drug)
Placebo Oral Tablet
Lead sponsor
Chinese University of Hong Kong (class: other)

Record details

Record id
cardio:ct-nct07052799
Content hash
b6ecf98a49a10d4f80b87592a8be44719a6950b0b5abaaf3021d797fdd6ed91d